Myrtucommulone from Myrtus communis exhibits potent anti-inflammatory effectiveness in vivo. by ROSSI A. et al.
Myrtucommulone from Myrtus communis Exhibits Potent Anti-
Inflammatory Effectiveness in Vivo
Antonietta Rossi, Rosanna Di Paola, Emanuela Mazzon, Tiziana Genovese, Rocco Caminiti,
Placido Bramanti, Carlo Pergola, Andreas Koeberle, Oliver Werz, Lidia Sautebin, and
Salvatore Cuzzocrea
Department of Experimental Pharmacology, University of Naples Federico II, Naples, Italy (C.P., L.S.); Istituto di Ricovero e
Cura a Carattere Scientifico Centro Neurolesi “Bonino-Pulejo,” Messina, Italy (A.R., R.D.P., E.M., T.G., P.B., S.C.); Departments
of Human Pathology (R.C.) and Clinical and Experimental Medicine and Pharmacology (S.C.), School of Medicine, University of
Messina, Messina, Italy; and Department of Pharmaceutical Analytics, Pharmaceutical Institute, University Tu¨bingen, Tu¨bingen,
Germany (C.P., A.K., O.W.)
Received July 11, 2008; accepted December 3, 2008
ABSTRACT
Myrtucommulone (MC), a nonprenylated acylphloroglucinol con-
tained in the leaves of myrtle (Myrtus communis), has been re-
ported to suppress the biosynthesis of eicosanoids by inhibition of
5-lipoxygenase and cyclooxygenase-1 in vitro and to inhibit the
release of elastase and the formation of reactive oxygen species in
activated polymorphonuclear leukocytes. Here, in view of the abil-
ity of MC to suppress typical proinflammatory cellular responses
in vitro, we have investigated the effects of MC in in vivo models
of inflammation. MC was administered to mice intraperitoneally,
and paw edema and pleurisy were induced by the subplantar and
intrapleural injection of carrageenan, respectively. MC (0.5, 1.5,
and 4.5 mg/kg i.p.) reduced the development of mouse carrag-
eenan-induced paw edema in a dose-dependent manner. More-
over, MC (4.5 mg/kg i.p. 30 min before and after carrageenan)
exerted anti-inflammatory effects in the pleurisy model. In partic-
ular, 4 h after carrageenan injection in the pleurisy model, MC
reduced: 1) the exudate volume and leukocyte numbers; 2) lung
injury (histological analysis) and neutrophil infiltration (myeloper-
oxidase activity); 3) the lung intercellular adhesion molecule-1 and
P-selectin immunohistochemical localization; 4) the cytokine lev-
els (tumor necrosis factor- and interleukin-1) in the pleural ex-
udate and their immunohistochemical localization in the lung; 5)
the leukotriene B4, but not prostaglandin E2, levels in the pleural
exudates; and 6) lung peroxidation (thiobarbituric acid-reactant
substance) and nitrotyrosine and poly (ADP-ribose) immunostain-
ing. In conclusion, our results demonstrate that MC exerts potent
anti-inflammatory effects in vivo and offer a novel therapeutic
approach for the management of acute inflammation.
Inflammatory diseases are accompanied by neutrophil in-
filtration, release of proinflammatory cytokines [such as tu-
mor necrosis factor (TNF)- and interleukin (IL)-1] and
bioactive mediators [e.g., leukotrienes (LTs) and prostaglan-
dins], and expression of adhesion molecules [intercellular
adhesion molecule (ICAM)-1 and P-selectin]. Several experi-
mental findings have shown that these mediators contribute
to tissue damage characteristic of the inflammatory process
(Fro¨de et al., 2001; Ueno and Oh-ishi, 2002; Cuzzocrea et al.,
2003; Fialkow et al., 2007; Mazzon and Cuzzocrea, 2007). In
addition, the elevation of intracellular Ca2 concentration
causes release of proteases (e.g., leukocyte elastase or cathep-
sin G) and formation of reactive oxygen species (ROS)
(Krause et al., 1990; Conner and Grisham, 1996; Parekh and
Penner, 1997), both of which destroy invading particles but
also damage cells and tissues of the host. Moreover, ROS
generation induced by intracellular Ca2 elevation causes
lipid peroxidation and DNA single-strand damage (Dix et al.,
1996; Pe´rez-De La Cruz et al., 2008). Interference with the
generation or action of these proinflammatory mediators ex-
erts beneficial effects in a variety of inflammation models,
including the carrageenan-induced paw edema and pleurisy
model (Moore, 2003; Morris, 2003).
Myrtle (Myrtus communis L., Myrtaceae) is widely distrib-
uted in the Mediterranean area and is used as a culinary
spice and an antiseptic and anti-inflammatory agent in folk
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medicine (Appendino et al., 2002). Nevertheless, only a small
number of studies have investigated the pharmacological
effects of the plant or its specific ingredients. For example,
myrtle extracts have been reported to be efficient as antibac-
terial (Al-Saimary et al., 2002), antihyperglycemic (Elfellah
et al., 1984; Onal et al., 2005), and analgesic (Le´vesque and
Lafont, 2000) treatment, but there is yet no clinical use of the
plant or its characteristic ingredients for treating any dis-
ease. Myrtucommulone (MC) and semimyrtucommulone are
unique oligomeric, nonprenylated acylphloroglucinols con-
tained in the leaves of myrtle. In particular, they are consid-
ered to be responsible for the antioxidative (Rosa et al., 2003)
and the antibacterial (Rotstein et al., 1974; Appendino et al.,
2002) activities of myrtle preparations. Moreover, MC po-
tently suppresses the biosynthesis of eicosanoids by inhibi-
tion of 5-lipoxygenase and cyclooxygenase-1, and it inhibits
the release of elastase and the formation of ROS, apparently
by blocking receptor-coupled Ca2 mobilization (Feisst et al.,
2005). It was shown recently that MC induces apoptosis of
cancer cells via the intrinsic mitochondrial pathway and only
marginally affects normal nontransformed cells (Tretiakova
et al., 2008).
Despite the strong effectiveness of MC as an anti-inflam-
matory agent in various experimental cell-based models, so
far, no data concerning the in vivo action of MC in inflam-
mation have been published. In this article, in view of the
ability of MC to suppress typical proinflammatory cellular
responses in vitro, we have investigated the effects of MC in
in vivo models of inflammation, such as mouse carrageenan-
induced paw edema and pleurisy, widely used for the in vivo
screening of anti-inflammatory compounds. Our data show
that MC is a highly efficient anti-inflammatory agent with a
promising pharmacological profile and potential therapeuti-
cal application.
Materials and Methods
Materials. MC (Fig. 1A) was isolated from myrtle leaves as de-
scribed previously (Appendino et al., 2002). The compound was dis-
solved in dimethyl sulfoxide (DMSO) (13.4 mg/ml) before being di-
luted with saline and kept in the dark at 20°C, and freezing/
thawing cycles were kept to a minimum. The final concentration of
DMSO in the MC solution was 2%. -Carrageenan type IV isolated
from Gigartina aciculaire and Gigartina pistillata was purchased
from Sigma-Aldrich (St. Louis, MO). Biotin and avidin were obtained
from DBA (Milan, Italy). All other reagents and compounds used
were obtained from Sigma-Aldrich.
Animals. Male adult CD1 mice (25–35 g; Harlan, San Pietro al
Natisone, Italy) were housed in a controlled environment and pro-
vided with standard rodent chow and water. Animal care complied
with Italian regulations on protection of animals used for experimen-
tal and other scientific purpose (Ministerial Decree 116192) and with
the European Economic Community regulations (Official Journal of
E.C. L 358/1 12/18/1986).
Fig. 1. Chemical structure of myrtucommulone (A) and effect of MC on mouse paw edema (B). Animals (n  10 for each experimental group) were
treated i.p. with 0.5, 1.5, and 4.5 mg/kg test compound (MC) or 5 mg/kg indomethacin or 2% DMSO 30 min before carrageenan subplantar injection.
Insert, percentages of inhibition caused by the treatments calculated from the relative areas under the curves. Data are expressed as mean  S.E.M.
, p  0.05; , p  0.01 versus 2% DMSO.
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Carrageenan-Induced Paw Edema. Mice were divided into
groups (n  10 for each group) and lightly anesthetized with enflu-
rane 4% mixed with 0.5 l/min O2 and 0.5 l/min N2O. Each group of
animals received subplantar administration of saline (0.05 ml) or 1%
-carrageenan type IV (w/v) (0.05 ml) in saline. The paw was marked
to immerse it always at the same extent in the measurement cham-
ber. The volume was measured by using a hydroplethismometer,
specially modified for small volumes (Ugo Basile, Comerio, Italy)
immediately before subplantar injection and 2, 4, and 6 h thereafter
(Posadas et al., 2004). The assessment of paw volume was always
performed double blind and by the same operator. The increase in
paw volume was calculated by subtracting the initial paw volume
(basal) from the paw volume measured at each time point.
Carrageenan-Induced Pleurisy. Mice were anesthetized with
4% enflurane mixed with 0.5 l/min O2 and 0.5 l/min N2O and sub-
mitted to a skin incision at the level of the left sixth intercostal space.
The underlying muscle was dissected, and saline (0.1 ml) or -car-
rageenan type IV 2% (w/v) (0.1 ml) was injected into the pleural
cavity. The skin incision was closed with a suture, and the animals
were allowed to recover. At 4 h after the injection of carrageenan, the
animals were killed by inhalation of CO2. The chest was carefully
opened, and the pleural cavity was rinsed with 1 ml of saline solution
containing heparin (5 U/ml) and indomethacin (10 	g/ml). The exu-
date and washing solution were removed by aspiration, and the total
volume was measured. Any exudate that was contaminated with
blood was discarded. The amount of exudate was calculated by sub-
tracting the volume injected (1 ml) from the total volume recovered.
Leukocytes in the exudate were resuspended in phosphate-buffered
saline (PBS) and counted with an optical light microscope in a
Burker’s chamber after vital trypan blue staining.
Experimental Design. For the carrageenan-induced paw edema
model in the treated group of animals, MC (0.5, 1.5, and 4.5 mg/kg)
(MC-treated groups) or indomethacin (5 mg/kg) (INDO-treated
group) was given i.p. 30 min before carrageenan. The vehicle-treated
group of mice received vehicle (2% DMSO i.p.) instead of MC 30 min
before carrageenan.
For carrageenan-induced pleurisy model in the treated group of
animals, MC (4.5 mg/kg) was given i.p. 30 min before and after
carrageenan (MC-treated group). The vehicle-treated group of mice
received vehicle (2% DMSO i.p.) instead of MC 30 min before and
after carrageenan. A group of animals underwent surgery and re-
ceived saline instead of carrageenan (sham group) and received
injections of vehicle (2% DMSO i.p.) or MC (4.5 mg/kg).
Determination of Myeloperoxidase Activity. Myeloperoxi-
dase (MPO) activity, an indicator of polymorphonuclear leukocyte
(PMN) accumulation, was determined as described previously
(Laight et al., 1994). At 4 h after intrapleural injection of carra-
geenan, lung tissues were obtained and weighed. Each piece of tissue
was homogenized in a solution containing 0.5% hexadecyltrimethyl-
ammonium bromide dissolved in 10 mM PBS, pH 7, and centrifuged
for 30 min at 20,000g at 4°C. An aliquot of the supernatant was then
allowed to react with a solution of tetramethylbenzidine (1.6 mM)
and 0.1 mM H2O2. The rate of change in absorbance was measured
spectrophotometrically at 650 nm. MPO activity was defined as the
quantity of enzyme degrading 1 	mol peroxide/min at 37°C and was
expressed in units per gram weight of wet tissue.
Histological Examination. Lung biopsies were taken 4 h after
injection of carrageenan. Lung biopsies were fixed for 1 week in 10%
(w/v) PBS-buffered formaldehyde solution at room temperature, de-
hydrated using graded ethanol, and embedded in Paraplast (Sher-
wood Medical, Mahwah, NJ). Tissue sections (thickness) were then
deparaffinized with xylene and stained with hematoxylin and eosin.
All sections were studied using light microscopy (Dialux 22 Leitz).
Immunohistochemical Localization of TNF-, IL-1, ICAM-1,
P-Selectin, Nitrotyrosine, and Poly(ADP-Ribose). At 4 h after
carrageenan administration, the lungs were fixed in 10% buffered form-
aldehyde, and 8-	m sections were prepared from paraffin-embedded
tissues. After deparaffinization, endogenous peroxidase was quenched
with 0.3% H2O2 in 60% methanol for 30 min. The sections were perme-
abilized with 0.1% Triton X-100 in PBS for 20 min. Nonspecific adsorp-
tion was minimized by incubating the section in 2% normal goat serum
in PBS for 20 min. Endogenous biotin or avidin-binding sites were
blocked by sequential incubation for 15 min with avidin and biotin. The
sections were then incubated overnight with primary anti-ICAM-1 (1:
500), anti-P-selectin (1:500), anti-TNF- (1:500), anti-IL-1 (1:500), an-
ti-nitrotyrosine (1:1000), and anti-poly(ADP-ribose) (PAR) (1:500) anti-
bodies or with control solutions. Sections were washed with PBS and
incubated with secondary antibody for 2 h at room temperature. To
confirm that the immunoreaction for the nitrotyrosine was specific,
some sections were also incubated with the primary antibody (anti-
nitrotyrosine) in the presence of excess of nitrotyrosine (10 mM) to
verify the binding specificity. To verify the binding specificity for
ICAM-1, P-selectin, TNF-, IL-1, and PAR, sections were also incu-
bated with the primary antibody (no secondary) or with the secondary
antibody (no primary). Under these conditions, no positive staining was
found in the sections, indicating that every immunoreaction was spe-
cific. Immunocytochemistry photographs were assessed by densitome-
try and scored by two independent blind situations. The assay was
carried out by using Optilab Graftek software on a Macintosh personal
computer (CPU G3-266).
Measurement of Prostaglandin E2 and LTB4 Levels. The
amount of prostaglandin E2 (PGE2) and LTB4 was evaluated in the
exudate at 4 h after the induction of pleurisy by carrageenan injec-
tion. The assay was carried out by using a colorimetric, commercial
kit (Calbiochem, San Diego, CA).
Total Protein Extraction and Western Blot Analysis for
COX-2. At 4 h after carrageenan administration, the lungs were
homogenized in a buffer containing 20 mM HEPES, pH 7.6, 1.5 mM
MgCl2, 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothre-
itol, 0.5 mM phenylmethylsulfonyl fluoride, 15 	g/ml trypsin inhib-
itor, 3 	g/ml pepstatin, 2 	g/ml leupeptin, 40 	M benzamidine, 1%
Nonidet P-40, 20% glycerol, and 50 mM NaF. The homogenates were
centrifuged at 10,000g for 15 min and at 4°C, the supernatant was
collected, and protein concentration was determined by Bio-Rad
protein assay (Bio-Rad, Hercules, CA). Equal amounts of protein (50
	g) were mixed with gel loading buffer (50 mM Tris, 10% SDS, 10%
glycerol, 10% 2-mercaptoethanol, and 2 mg/ml bromphenol) in a ratio
of 1:1, boiled for 3 min, and centrifuged at 10,000g for 10 min. Each
sample was loaded and electrophoresed on a 10% SDS-polyacryl-
amide gel. The proteins were transferred on to nitrocellulose mem-
branes. The membranes were blocked with 0.1% PBS-Tween con-
taining 5% nonfat dry milk. After the blocking, the membranes were
incubated with the primary antibody overnight at 4°C. Rabbit mono-
clonal antibody anti-COX-2 was diluted 1:1000 in 0.1% PBS-Tween.
After the incubation, the membranes were washed six times with
0.1% PBS-Tween and were incubated for 1.5 h at room temperature
with horseradish peroxidase-conjugated anti-mouse secondary anti-
bodies (Dako North America, Inc., Carpinteria, CA) diluted 1:1000 in
0.1% PBS-Tween containing 5% nonfat dry milk. The membranes
were washed, and protein bands were detected by an enhanced
chemiluminescence system (GE Healthcare, Chalfont St. Giles, UK).
Densitometric analysis was performed with a Fluor S quantitative
imaging system (Bio-Rad).
Measurement of TNF- and IL-1 Levels. TNF- and IL-1
levels were evaluated in the exudates at 4 h after the induction of
pleurisy by carrageenan injection. The assay was carried out by
using a colorimetric, commercial enzyme-linked immunosorbent as-
say kit (Calbiochem).
Thiobarbituric Acid-Reactant Substance Measurement.
Thiobarbituric acid-reactant substance measurement, which is con-
sidered a good indicator of lipid peroxidation in the lung tissues, was
carried out. Tissues, collected 4 h after carrageenan administration,
were homogenized in 1.15% KCl solution. An aliquot (0.1 ml) of the
homogenate was added to a reaction mixture containing 0.2 ml of
8.1% SDS, 1.5 ml of 20% acetic acid, pH 3.5, 1.5 ml of 0.8% thiobar-
bituric acid, and 0.7 ml of distilled water. Samples were then boiled
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for 1 h at 95°C and centrifuged at 3000g for 10 min. The optical
density at 650 nm (OD650) was measured using an enzyme-linked
immunosorbent assay microplate reader (SLT-Labinstruments, Sal-
zburg, Austria). Thiobarbituric acid-reactant substances were calcu-
lated by comparison with OD650 of standard solutions of 99% 1,1,3,3-
tetramethoxypropan and 99% malondialdehyde bis(dimethyl acetal).
Statistical Procedures. All values in the figures and text are
expressed as means  S.E. of n observations, where n represents the
number of animals studied. In the experiments involving histology or
immunohistochemistry, the figures shown are representative of at
least three independent experiments performed on different experi-
mental days. The data were analyzed by one-way analysis of vari-
ance followed by a Bonferroni post hoc test for multiple comparisons.
A p value less than 0.05 was considered significant.
Results
Carrageenan-Induced Mouse Paw Edema
Injection of carrageenan into the mouse paw produced a
marked increase of paw volume, reaching its maximal effect
after 4 h (Fig. 1B). Pretreatment of mice with MC (0.5, 1.5,
and 4.5 mg/kg), injected 30 min before carrageenan, dose-
dependently attenuated the inflammatory response at 4 and
6 h (Fig. 1B). In mice treated with 0.5, 1.5, and 4.5 mg/kg MC,
the peak of the response to carrageenan at 4 h was reduced
by 31, 54, and 68%, respectively, whereas indomethacin (5
mg/kg), a nonsteroidal anti-inflammatory drug used as a
reference, caused 57% inhibition. Comparison of the areas
under the curves of each group, between 2 and 6 h after
carrageenan injection, yielded similar degrees of inhibition
(Fig. 1B, insert).
Carrageenan-Induced Pleurisy
Inflammatory Response To further assess the effec-
tiveness of MC as an anti-inflammatory agent in vivo, the
compound was tested in carrageenan-induced pleurisy in
mice. Injection of carrageenan into the pleural cavity of
mice (2% DMSO group) elicited an acute inflammatory
response characterized by the accumulation of fluid (Fig.
Fig. 2. Effect of MC on carrageenan-induced pleurisy. Thirty min before and after carrageenan (CAR) or saline (SHAM) intrapleural injection, mice
(n 10 for each experimental group) were treated i.p. with 4.5 mg/kg MC or 2% DMSO. The exudate volume (A) and PMN accumulation (B) in pleural
cavity and lung MPO activity (C) were assessed 4 h after carrageenan or saline injection. Data are expressed as mean  S.E.M. , p  0.05; , p 
0.01 versus SHAM; ††, p  0.01 versus 2% DMSO.
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2A) that contained large numbers of PMNs (Fig. 2B) com-
pared with the corresponding sham animals. As observed
in carrageenan-induced paw edema, MC (4.5 mg/kg i.p., 30
min before and after the carrageenan) significantly (p 
0.01) inhibited the inflammatory response induced by in-
trapleural injection of carrageenan, as demonstrated by
the significant attenuation of exudate formation (Fig. 2A)
and PMN infiltration (Fig. 2B). The action of MC on cell
migration to the inflammatory site was further supported
by the measurement of lung MPO activity, an index of
neutrophil infiltration characteristic of the inflammatory
process (Fro¨de and Medeiros, 2001). In fact, MC (4.5 mg/kg
i.p., 30 min before and after the carrageenan) significantly
(p  0.01) reduced the increase of lung MPO activity in-
duced by carrageenan administration (Fig. 2C).
Histological examination of lung sections from sham-
treated (Fig. 3A) and carrageenan-treated (Fig. 3B) mice
showed that injection of carrageenan induced edema, lung
injury, and infiltration of inflammatory cells within 4 h
(Fig. 3B, see arrows). Treatment with MC (4.5 mg/kg i.p.,
30 min before and after carrageenan) (Fig. 3C) signifi-
cantly attenuated the edema and the infiltration of PMNs
into the lung, leading to a clear reduction of tissue injury.
Expression of ICAM-1 and P-Selectin. Carrageenan-
induced neutrophil infiltration in lung tissues was associ-
ated with expression of adhesion molecules. In fact, posi-
tive staining for ICAM-1 (Fig. 4, A and A1, see arrows;
Table 1) and P-selectin (Fig. 4, C and C1, see arrows; Table
1) was increased along the bronchial epithelium and in
vessels from carrageenan-treated (4 h) mice. Less positive
staining for ICAM-1 and P-selectin was obvious in the
lungs of carrageenan-treated mice that received MC (4.5
mg/kg i.p., 30 min before and after the carrageenan) (Fig.
4, B and D; Table 1).
LTB4 and PGE2 Levels. Because MC is an inhibitor of
5-lipoxygenase and COX-1, the metabolites of these enzymes,
i.e., LTB4 and PGE2, have been determined in pleural exu-
dates (Fig. 5, A and B). In comparison with the corresponding
sham animals, the levels of LTB4 and PGE2 were signifi-
cantly (p  0.01) elevated in pleural exudates from 2%
DMSO-treated mice at 4 h after carrageenan administration.
Treatment with MC (4.5 mg/kg i.p., 30 min before and after
the carrageenan) significantly decreased (p 0.01) the levels
of LTB4, whereas it did not affect PGE2 production (Fig. 5, A
and B) and lung COX-2 expression (data not shown).
TNF- and IL-1 Levels. Production of inflammatory
mediators (e.g., TNF- and IL-1) by neutrophils represents
a pivotal biochemical event to maintain and propagate the
inflammatory response within injured tissues (Fro¨de et al.,
2001). In comparison with the corresponding sham animals,
Fig. 3. Effect of MC on lung injury. Compared with lung sections taken from sham-treated animals (A), lung sections from carrageenan-treated mice
(B) demonstrated edema and PMN infiltration (see arrows). Lung sections from carrageenan-treated mice that received MC exhibited reduced tissue
injury and inflammatory cell infiltration (C). Figure is representative of all the animals in each group.
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the levels of TNF- and IL-1 were significantly (p  0.01)
elevated in pleural exudates from 2% DMSO-treated mice at
4 h after carrageenan administration (Fig. 5, C and D). Treat-
ment with MC (4.5 mg/kg i.p., 30 min before and after the
carrageenan) significantly decreased (p  0.01) the levels of
these proinflammatory cytokines (Fig. 5, C and D). In addi-
tion, tissue sections obtained from carrageenan-treated mice
(2% DMSO group) showed positive staining for TNF- (Fig. 6,
A and A1; Table 1) and IL-1 (Fig. 6, C and C1; Table 1). In
carrageenan-treated mice, which received MC, the staining
for TNF- and IL-1 was significantly (p  0.01) and visibly
reduced (Fig. 6, B and D; Table 1) in comparison with 2%
DMSO-treated animals.
Lipid Peroxidation, Nitrotyrosine, and PAR Forma-
tion. Infiltration of neutrophils into tissues and the subse-
quent production of ROS induce lipid peroxidation, nitrosa-
tive stress, and DNA damage (Azad et al., 2008). To evaluate
the effects of MC on lipid peroxidation in the lung, the levels
of thiobarbituric acid-reactant substance were measured. As
shown in Fig. 7A, thiobarbituric acid-reactant substance lev-
els were significantly (p  0.01) increased in the lung of
carrageenan-treated mice (2% DMSO group) compared with
Fig. 4. Effect of MC on the immunohistochemical localization of ICAM-1 and P-selectin in the lung. Immunohistochemical analyses of sections from
carrageenan-treated mice showed positive staining for ICAM-1 (A and A1, see arrows) and P-selectin (C and C1, see arrows). The intensity of staining
for ICAM-1 (B) and P-selectin (D) was markedly reduced in tissue sections obtained from MC-treated mice. The figures are representatives of all the
animals in each group.
TABLE 1
Typical densitometry evaluation: analysis of ICAM-1, P-selectin, TNF- , IL-1 , nitrotyrosine, and PAR
The assay was carried out by using Optilab Graftek software. Data are expressed as means  S.E. of percentage of total tissue area. In particular, the densitometry analysis
was carried out in the section in which the lung was orientated to observe all the histological portions.
Percentage of Total Lung Tissue Area
ICAM-1 P-Selectin TNF- IL-1 Nitrotyrosine PAR
CAR  2% DMSO 5.1  0.5 6.0  0.5 5.2  0.5 5.1  0.5 6.4  0.5 6.1  0.5
CAR  MC 1.0  0.08** 0.9  0.08** 1.0  0.5** 1.1  0.08** 1.0  0.08** 1.1  0.08**
** p  0.01 vs. CAR  2% DMSO.
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the corresponding sham animals. In mice treated with MC
(4.5 mg/kg i.p., 30 min before and after carrageenan), lung
thiobarbituric acid-reactant substance levels were signifi-
cantly (p  0.01) reduced in comparison with those of 2%
DMSO-treated mice (Fig. 7A). Nitrosative stress and DNA
damage were evaluated by immunohistological staining for
nitrotyrosine (Fig. 7, B and B1, see arrows) and PAR (Fig. 7,
D and D1, see arrows) performed on lung sections taken 4 h
after carrageenan injection, respectively. MC (4.5 mg/kg i.p.,
30 min before and after carrageenan) significantly (p  0.01)
attenuated the staining for nitrotyrosine (Fig. 7C, see ar-
rows) and PAR (Fig. 7E, see arrows) (Table 1) in comparison
with 2% DMSO-treated animals.
Discussion
MC, an oligomeric, nonprenylated acylphloroglucinol
contained in the leaves of myrtle, exhibits inhibitory prop-
erties in vitro visualized by the suppression of various
functional cellular leukocyte responses, including the bio-
synthesis of prostaglandins and LT, the release of leuko-
cyte elastase, and the generation of ROS (Feisst et al.,
2005). In view of these findings, MC and myrtle prepara-
tions have been suggested as a potential therapeutic for
the treatment of inflammatory and allergic diseases. To
explore the anti-inflammatory potential of MC to allow the
judgment of its therapeutic benefit for the treatment of
inflammation in humans, data from appropriate in vivo
studies using animal models are required.
To this aim, we have investigated the effect of MC in in
vivo models of acute inflammation in mice, such as carrag-
eenan-induced paw edema and pleurisy. In fact, these in-
flammatory models are widely used to determine the anti-
inflammatory activity of compounds in vivo (Moore, 2003;
Morris, 2003). In particular, the mouse paw edema has been
used to screen for new anti-inflammatory drugs, whereas
carrageenan-induced pleurisy is more suitable to study the
mechanisms involved in the anti-inflammatory action of test
compounds.
Injection of carrageenan in the mouse paw induced an
acute inflammatory response (0–6 h) characterized by an
increase in vascular permeability and PMN infiltration re-
lated to edema formation at the site of inflammation (Posa-
das et al., 2004). The i.p. treatment of mice with MC reduced
the development of edema induced by carrageenan at 4 and
6 h in a dose-dependent manner. In particular, MC seemed to
Fig. 5. Effect of MC on LTB4, PGE2, TNF-, and IL-1 levels in the pleural exudates. Thirty minutes before and after CAR or saline (SHAM)
intrapleural injection, mice (n  10 for each experimental group) were treated i.p. with 4.5 mg/kg MC or 2% DMSO. The LTB4 (A), PGE2 (B), TNF-
(C), and IL-1 (B) levels in the pleural were assessed 4 h after carrageenan or saline injection. Data are expressed as mean S.E.M. , p 0.01 versus
SHAM; ††, p  0.01 versus 2% DMSO.
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be more potent than indomethacin, confirming a remarkable
anti-inflammatory effectiveness of the compound in vivo.
The onset of local inflammation after carrageenan is linked
to generation of ROS, release of leukocyte elastase, and for-
mation of LT from neutrophils. Because MC blocked these
neutrophil responses in vitro, we attribute the effectiveness
of MC in carrageenan-induced paw edema to such interrela-
tions. This hypothesis is supported by the results obtained in
the in vivo model of acute inflammation, the carrageenan-
induced pleurisy, which enables the analysis of the cellular
and molecular mechanisms responsible for the anti-inflam-
matory action of the test compound. In fact, one possible
mechanism by which MC attenuated carrageenan-induced
pleurisy (exudate volume and cell number) might be the
reduction of PMN infiltration by down-regulating the adhe-
sion molecules ICAM-1 and P-selectin. In particular, we ob-
served that the appearance of P-selectin on the endothelial
vascular wall and the up-regulation of expression of ICAM-1
on endothelial cells induced by acute lung inflammation (4 h
after carrageenan administration) was abolished by MC
treatment. As a consequence, MC might interrupt the inter-
actions between neutrophils and endothelial cells, both at the
early rolling phase mediated by P-selectin and at the late
firm adhesion phase mediated by ICAM. The reversal of
increased expression of the adhesion molecules in the lung
tissue of carrageenan-treated mice treated with MC corre-
lated with the reduction of leukocyte infiltration, as assessed
by measuring the granulocyte-specific MPO activity, and
with the attenuation of lung tissue damage as evaluated by
histological examination. Moreover, our results demonstrat-
ing that MC inhibits LTB4 generation in the pleural exudates
of carrageenan-treated mice are in agreement with the report
of Feisst et al. (2005), who have showed that MC potently
inhibits the formation of LT (IC50  1.8 	M) by interference
with 5-lipoxygenase (Feisst et al., 2005). Because 5-lipoxy-
genase regulates the expression of adhesion molecules (Cuz-
zocrea et al., 2003), it is reasonable to speculate that MC
might reduce their expression via inhibition of LT synthesis.
Leukotriene B4 is a potent chemotactic and chemokinetic
factor that recruits neutrophils (Ford-Hutchinson et al.,
1980), and MC clearly reduced the number of PMN in the
exudates of inflamed mouse pleurisy. However, more de-
Fig. 6. Effect of MC on the TNF- and IL-1 immunohistochemical localization in the lung. Immunohistochemical analyses of sections from
carrageenan-treated mice showed positive staining for TNF- (A and A1, see arrows) and IL-1 (C and C1, see arrows). The intensity of staining for
TNF- (B) and IL-1 (D) was markedly reduced in tissue sections obtained from MC-treated mice. The figures are representatives of all the animals
in each group.
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tailed studies are needed to reveal a clear interrelation be-
tween these processes.
It is interesting that in our experimental conditions, MC
did not inhibit PGE2 generation. Thus, although there is good
evidence in this and in other models of inflammation that an
enhanced formation of prostanoids contributes to the patho-
physiology of local inflammation (Futaki et al., 1993; Mitchell
et al., 1993; Salvemini et al., 1995; Harada et al., 1996;
Fig. 7. Effect of MC on lung lipid peroxidation (A) and on the immunohistochemical localization of nitrotyrosine (B and B1) and PAR (D and D1) in
the lung. Thirty minutes before and after CAR or saline (SHAM) intrapleural injection, animals (n  10 for each experimental group) were treated
i.p. with 4.5 mg/kg MC or 2% DMSO. Thiobarbituric acid-reactant substance levels (A) were determined in the lung 4 h after carrageenan injection.
Data are expressed as mean  S.E.M. , p  0.01 versus SHAM; ††, p  0.01 versus 2% DMSO. Immunohistochemical analyses of sections from
carrageenan-treated mice showed positive staining for nitrotyrosine (B and B1, see arrows) and PAR (D and D1, see arrows). The intensity of staining
for nitrotyrosine (C) and PAR (E) was markedly reduced in tissue sections obtained from MC-treated mice. The figures are representatives of all the
animals in each group.
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Sautebin et al., 1998), the anti-inflammatory action of MC
does not involve PGE2 generation.
It has been suggested that neutrophil activation in lung
injury represents an important source of other inflammatory
molecules, such as TNF-, IL-1, and ROS (Conner and
Grisham, 1996). Moreover, various studies have shown
clearly that inhibition of TNF- and IL-1 formation signif-
icantly prevents the development of the inflammatory pro-
cess (Mageed et al., 1998; Fro¨de et al., 2001; Mukherjee et al.,
2005). Our results demonstrate that MC attenuates the pro-
duction of TNF- and IL-1 in pleural exudates and lungs of
carrageenan-treated mice, which might contribute to the
mechanism underlying the anti-inflammatory effectiveness
of MC in carrageenan-induced pleurisy. Alternatively, the
inhibition of TNF- and IL-1 formation by MC might reflect
its inhibitory effects on neutrophil infiltration (Fro¨de et al.,
2001; Mazzon and Cuzzocrea, 2007). With regard to ROS, it
is well known that their generation by neutrophils is respon-
sible for lipid peroxidation, nitrosative stress, and DNA sin-
gle-strand damage (Dix et al., 1996), which then cause cellu-
lar dysfunction, damage, and eventually cell death (Carmody
and Cotter, 2001). Lung damage because of ROS production
is associated with high concentrations of thiobarbituric acid-
reactant substances, which are considered a good indicator of
lipid peroxidation, whereas nitration of tyrosine and PARS
activation can be considered as global biomarker of nitrosa-
tive stress (Beckman, 1996) and DNA damage, respectively.
The reduced lipid peroxidation, nitrosative stress, and DNA
damage observed in the present study suggest that MC de-
creases ROS production in the carrageenan-treated mice.
Because MC is able to suppress ROS generation in isolated
PMN stimulated with N-formyl-L-methionyl-L-leucyl-L-phe-
nylalanine by its ability to block receptor-coupled Ca2 mo-
bilization at submicromolar concentrations (Feisst et al.,
2005), these observed in vivo actions could be related to this
effect. In addition, a mechanism has been identified where G
protein-coupled receptor-mediated Ca2 signals are trans-
lated into mitochondrion-derived superoxide, which up-regu-
lates the expression of ICAM-1 and elicits leukocyte/endothe-
lial cell firm adhesion (Hawkins et al., 2007). Thus, the
inhibitory effect of MC on ROS formation and on the expres-
sion of adhesion molecules might eventually depend on in-
terference with intracellular Ca2 signaling. In addition, MC
may also have a direct effect on oxidative enzymes, in accor-
dance with the antioxidant activity observed by others (Rosa
et al., 2003).
Taken together, these findings indicate that MC exerts
potent anti-inflammatory effects in vivo, as evidenced by its
inhibitory action in two well known models of acute experi-
mental inflammation. Therefore, we successfully expanded
our initial observations that MC acts as an anti-inflamma-
tory agent based on its inhibitory action on 5-lipoxygenase
(Feisst et al., 2005) and other proinflammatory leukocyte
functions.
In conclusion, our data suggest that the suppression of
adhesion molecules and inhibition of LTB4 generation and
PMN infiltration are part of the significant mechanisms of
lung injury protection by MC. Our findings further support a
future potential use of MC as a therapeutic agent in the
therapy of conditions associated with acute inflammation.
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